Price transparency
What is disclosed before intake, not a clinical rating.
SurpassMD offers online compounded semaglutide and tirzepatide care through independent clinicians, with a clear distinction between discounted first subscriptions and standard renewal prices. The monthly renewal figures are $219 for injectable semaglutide and $309 for tirzepatide. Its main complication is the cancellation paperwork: different public policies describe different refund rights, so get the controlling agreement before paying.
SurpassMD does not pay us. We review it so you can compare it with the programs that do. Disclosure
SurpassMD publishes its price before the medical intake — you can see what it costs without handing over your health history first.
On this page
SurpassMD at a glance
- Price visibility
- Published before intake
- Pharmacy information
- OpenLoop (linked clinical consent; confirm assigned professional practice)
- Where it operates
- Company advertises all 50 states and Washington, DC, subject to state rules, clinician review and pharmacy availability
The verdict
SurpassMD shows its price before the medical intake and is clear about what that price covers and what conditions come with it. It ranks 7 of 293 among the programs we review on price transparency.
The score beside SurpassMD's name rates how much it tells you before the medical intake — the price, the pharmacy and the terms — not how cheap it is.
Considering SurpassMD?
Confirm the plan, billing terms and availability before you begin.
What do you get with SurpassMD?
- An online health assessment made available to an independent licensed clinician, with medication prescribed only when appropriate.
- Compounded injectable semaglutide and tirzepatide, plus a separate oral semaglutide plan rather than one interchangeable product.
- Medication, provider review, pharmacy shipping and ongoing support described in the selected program without a separate membership fee.
- A direct-pay service with no insurance billing and a specific exclusion for Medicare and Medicaid beneficiaries.
- A platform operated by Life Vitality LLC, with the medical consent linking patients to OpenLoop’s separate clinical consent and privacy notice.
How does SurpassMD work?
Choose the supply term before comparing prices
The headline starting prices come from discounted first subscriptions for a twelve-month supply term. The drug pages separately show standard renewal figures for thirty-day, three-month, six-month and twelve-month options. Compare the same supply term and normal payment obligation rather than assuming the largest discount describes an independent monthly purchase.
Complete the medical review
The platform sends your health history to an independent licensed provider who can prescribe a particular treatment, recommend another option or decline medication. The medical consent links to OpenLoop documents for the clinical relationship. Confirm the exact professional practice, assigned clinician and location eligibility before care begins.
Read the prescription and pharmacy details
If approved, a licensed compounding pharmacy prepares the medicine and ships it with instructions. Ask for the actual dispenser, ingredients, concentration, quantity, intended supply and storage requirements. Injectable and oral semaglutide are separate offers; a quoted price for one should not be assumed to cover the other.
Resolve renewal and refund terms in writing
The separate cancellation policy requires seventy-two hours’ notice before billing and restricts ordinary refunds. The general terms and medical consent instead describe refunds for periods whose medication has not been ordered or shipped. Ask which provisions govern your purchase and retain the answer with the billing schedule.
How much does SurpassMD cost?
Injectable semaglutide thirty-day standard renewal $219; first subscription $175 with discount. Lower headlines use longer supply terms.
Injectable tirzepatide thirty-day standard renewal $309; first subscription $247 with discount. Lower headlines use longer supply terms.
Company advertises all 50 states and Washington, DC, subject to state rules, clinician review and pharmacy availability
Injectable semaglutide’s thirty-day plan lists $175 for the first discounted subscription and a $219 standard renewal. Tirzepatide lists $247 initially and $309 at standard renewal for thirty days. The $114 and $177 headline figures belong to twelve-month supply terms with introductory discounts; they are not the ordinary monthly renewal prices. The website says the selected term’s price does not rise with dose.
- Semaglutide’s standard monthly equivalents are $195 for a three-month term, $180 for six months and $143 for twelve months, compared with discounted first-subscription equivalents of $156, $144 and $114. Ask for the actual full amount collected and the supply schedule before committing to a longer term.
- Tirzepatide’s listed standard monthly equivalents are $299 for three months, $275 for six months and $222 for twelve months. Introductory figures for those terms are $232, $220 and $177. These longer-term equivalents should not replace the $309 thirty-day renewal when comparing independently renewable monthly plans.
- The oral semaglutide page lists a separate $183 introductory price for a one-month supply, including provider review, medication, shipping and ongoing support. Its normal renewal is not established by that introductory statement. Do not apply the injectable plan’s renewal or supply assumptions to the oral preparation.
- The separate refund policy says the first month is charged when intake is completed, with a full refund for initial medical disqualification. It requires cancellation at least seventy-two hours before billing; otherwise another cycle can be charged and cancellation takes effect the following cycle. Ordinary cancellations are described as nonrefundable.
- The general terms and medical consent contain broader wording allowing refunds unless the medication for that period has already been ordered or shipped. That differs materially from the separate policy. Obtain the applicable refund and cancellation agreement before payment instead of relying on the broad cancel-anytime headline.
- The homepage advertises service in all fifty states and Washington, DC, subject to clinician review, state requirements and pharmacy availability. The service is cash pay, is not billed to insurance and excludes Medicare or Medicaid beneficiaries. Confirm both personal eligibility and the selected medicine’s shipping availability before authorizing charges.
Considering SurpassMD?
Confirm the plan, billing terms and availability before you begin.
Who is SurpassMD best for?
A good fit if
- Adults comparing clearly separated first-subscription and renewal prices
- People comfortable using an independent clinical network for online care
- Patients willing to settle conflicting cancellation documents before purchase
Look elsewhere if
- Shoppers treating the lowest annual-term headline as an ordinary monthly price
- Medicare or Medicaid beneficiaries under the stated program exclusion
- Anyone relying on a cancel-anytime slogan as a complete refund promise
Considering SurpassMD?
Confirm the plan, billing terms and availability before you begin.
What are SurpassMD's pros and cons?
Pros
- Thirty-day standard renewal prices are explicitly listed
- Longer supply terms distinguish introductory and normal pricing
- The platform operator and separate clinical consent are identified
- Medication pages describe included provider review and delivery
Cons
- Separate public refund documents conflict
- The lowest headline prices use long supply terms
- Specific pharmacy and prescription details require confirmation
- Cash-pay exclusions limit who can participate
The pharmacy behind the medicine
It names its pharmacy. SurpassMD discloses OpenLoop (linked clinical consent; confirm assigned professional practice) as its compounding partner. That matters more here than the price does: a compounded medicine is only as good as the pharmacy that made it, and a company willing to name one is a company you can go and check.
A compounded drug is mixed to order by a pharmacy rather than manufactured and released as a finished product, so the FDA has not reviewed the specific preparation you are prescribed for safety, effectiveness or quality. That is true of every compounded program, including the highest-scoring ones.
What else do people ask about SurpassMD?
What are the normal monthly renewal prices?
The thirty-day injectable plans list $219 for semaglutide and $309 for tirzepatide at standard renewal. The initial discounted figures are $175 and $247. Longer supply terms have different monthly equivalents and may involve a larger payment or commitment, so compare the actual term you plan to buy.
Why does the homepage show $114 and $177?
Those are introductory monthly equivalents associated with the twelve-month supply terms. The drug pages identify discounts as applying to the first subscription and list separate standard renewal rates. They do not describe a new patient’s ongoing independent thirty-day purchase at those headline amounts.
Who provides medical care?
Life Vitality LLC operates SurpassMD as a platform. The service describes independent licensed clinicians, and its medical consent links to OpenLoop’s clinical consent and privacy notice. Confirm the actual professional practice and clinician assigned to your state; the platform does not itself make the prescribing decision.
Can I cancel and get a refund?
The separate policy requires seventy-two hours’ advance notice and generally rejects ordinary cancellation refunds. The general terms and medical consent describe broader refunds before medication is ordered or shipped. Ask which agreement controls your purchase and keep the written response before authorizing a recurring subscription.
Is oral semaglutide the same priced plan?
No. The oral page advertises a separate $183 introductory monthly offer with a one-month supply. That does not establish its standard renewal or make it interchangeable with the injectable plan. Obtain the exact formulation, prescription instructions and normal future charge for the oral option.
Can I use insurance or enroll in any state?
The service is direct pay and does not bill insurance. It expressly excludes Medicare and Medicaid beneficiaries. SurpassMD advertises all fifty states and Washington, DC, while qualifying access by state rules, clinician review and pharmacy availability. Confirm personal and medication-specific eligibility before purchase.
Sources for this review
Company information and terms used for this review. These sources describe the service; they do not establish treatment outcomes.
How it compares
SurpassMD ranks 7 of 293 on our price-transparency score. Every prescription GLP-1 program we review is scored on the same question: can you see the price before you hand over your health history? The full list is on the prescription GLP-1 review index.
Because SurpassMD shows a price before the intake, it is also ranked on our GLP-1 telehealth ranking, our compounded semaglutide ranking and our compounded tirzepatide ranking.
Compounded semaglutide $149/month, billed monthly; medication, supplies, provider care, messaging and standard shipping included.Show the full pricing note
Compounded semaglutide advertised at $89/month, including online consultation and shipping, with no membership fee or dose-based price increase.Show the full pricing note
$179/mo standing, $99 for the first month (compounded, sold only as "GLP-1/GIP" — its sales page never names the molecule, so this is the same product as the cell beside it)Show the full pricing note
$175/mo month-to-month (compounded weekly injection, the same price at every dose); $99/mo only on the annual plan, billed $1,188 up frontShow the full pricing note
Generic weight-loss founding offer $199 every 4 weeks; medicine-specific semaglutide offer and ongoing month-to-month total not established.Show the full pricing note
Read this before you start
Prices change — confirm on SurpassMD's own site before you commit. This page is informational and not medical advice: a GLP-1 is a prescription drug, and whether one suits you is a decision for a licensed clinician who knows your history. How we choose what appears here, and what we are paid for, is set out in our editorial policy.